Athanasios Vassilopoulos
Impact in
-
- Liver Disease Diagnosis and Treatment
-
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Free Radicals and Antioxidants
Papers in
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 2
-
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Eleftherios Mylonakis (12 shared papers)Stephanos P. Vassilopoulos (11 shared papers)Markos Kalligeros (10 shared papers)Mazen Noureddin (1 shared paper)David W. Victor (1 shared paper)Fadi Shehadeh (11 shared papers)Panagiota Papazafiri (3 shared papers)Maria Koufaki (3 shared papers)
- Journals
- Clinical Gastroenterology and Hepatology (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Open Forum Infectious Diseases (2 papers)Inflammatory Bowel Diseases (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGreeceHungary
In The Last Decade
Athanasios Vassilopoulos
15 papers receiving 346 citations
Athanasios Vassilopoulos's Hit Papers
Peers
Comparison fields: 5 of 60
- Epidemiology 115
- Organic Chemistry 91
- Hepatology 20
- Biochemistry 18
- Biochemistry 13
Countries citing papers authored by Athanasios Vassilopoulos
This map shows the geographic impact of Athanasios Vassilopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Vassilopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Vassilopoulos more than expected).
Fields of papers citing papers by Athanasios Vassilopoulos
This network shows the impact of papers produced by Athanasios Vassilopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Vassilopoulos. The network helps show where Athanasios Vassilopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside Athanasios Vassilopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 Hit paper breakdown → | 2023 | 121 |
| 2 | 2009 | 54 | |
| 3 | 2004 | 53 | |
| 4 | 2023 | 44 | |
| 5 | 2022 | 22 | |
| 6 | 2006 | 20 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 1 |
About Athanasios Vassilopoulos
Athanasios Vassilopoulos is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine, Hematology, Hepatology and Molecular Biology, having authored 15 papers that have together received 351 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Cardiac electrophysiology and arrhythmias (2 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Hepatitis B Virus Studies (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper) and Coenzyme Q10 studies and effects (1 paper). The work is most often cited by research in Epidemiology (115 citations), Organic Chemistry (91 citations), Hepatology (20 citations), Biochemistry (18 citations) and Biochemistry (13 citations). Athanasios Vassilopoulos has collaborated with scholars based in United States, Greece and Hungary. Frequent co-authors include Eleftherios Mylonakis, Stephanos P. Vassilopoulos, Markos Kalligeros, Mazen Noureddin, David W. Victor, Fadi Shehadeh, Panagiota Papazafiri, Maria Koufaki, Theodora Calogeropoulou and András Varró. Their work appears in journals such as Clinical Gastroenterology and Hepatology, Bioorganic & Medicinal Chemistry, Open Forum Infectious Diseases, Inflammatory Bowel Diseases and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.